H Ninomiya, T Hanada, M Nakazawa, Y Aoki, A Shibuya, T Nagasawa, T Abe. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAntineoplastic Combined Chemotherapy Protocols/therapeutic useCastor Oil/adverse effectsCastor Oil/analogs & derivativesCytarabine/analogs & derivativesCytarabine/therapeutic useErythroblasts/drug effectsErythroblasts/immunologyHematopoietic Stem Cells/drug effectsHematopoietic Stem Cells/immunologyHumansLeukemia, Myeloid, Acute/bloodLeukemia, Myeloid, Acute/drug therapyMaleRed-Cell Aplasia, Pure/chemically inducedRed-Cell Aplasia, Pure/immunologySolvents/adverse effects
Substances： See more » SolventsCytarabinepolyethoxylated castor oilCastor Oilenocitabine
Year: 1987 PMID： 3120451
Source DB: PubMed Journal: Nihon Ketsueki Gakkai Zasshi ISSN： 0001-5806